Big Gain For Pasithea Therapeutics Corp.
Fri, Nov 28, 2025 at 07:43 PM
Pasithea Therapeutics Corp. (KTTA:NASDAQ) shot up at $1.47, a gain of 38.7%. On Fri, Nov 28, 2025, KTTA:NASDAQ touched a New 2-Week High of $1.47. The stock got featured on our News Catalysts scanner on Fri, Nov 28, 2025 at 03:31 PM in the 'MISCELLANEOUS' category. From Mon, Nov 17, 2025, the stock recorded 50.00% Up Days and 33.33% Green Days
The stock spiked on Fri, Nov 28, 2025 at $2.06 with a volume of 164M+.
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 250.8%
- Twin Vee Powercats Co. (VEEE:NASDAQ), 45.51%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 38.68%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 35.62%
- Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT), 32.42%
- Nature Wood Group Limited (NWGL:NASDAQ), 30.56%
- OneMedNet Corporation (ONMD:NASDAQ), 30.28%
- HeartBeam, Inc. (BEAT:NASDAQ), 27.55%
- Next Technology Holding Inc. (NXTT:NASDAQ), 24.89%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 23.91%